We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFA
501
DELISTED
Informatica
INFA
$4.37M 0.03%
+179,400
New +$3.7M
SOUL.U
502
Soulpower Acquisition Corp Units
SOUL.U
$4.35M 0.03%
+427,900
New +$4.3M
LNN icon
503
Lindsay Corp
LNN
$1.16B
$4.33M 0.03%
30,000
– –
SU icon
504
Suncor Energy
SU
$77.7B
$4.31M 0.03%
115,100
– –
UL icon
505
Unilever
UL
$131B
$4.28M 0.03%
62,164
-7,900
-11% -$554K
FHI icon
506
Federated Hermes
FHI
$4.4B
$4.28M 0.03%
+96,493
New +$3.97M
TSN icon
507
Tyson Foods
TSN
$20.2B
$4.23M 0.03%
75,600
– –
IR icon
508
Ingersoll Rand
IR
$33B
$4.23M 0.03%
50,800
– –
YORW icon
509
York Water
YORW
$505M
$4.22M 0.03%
133,643
– –
TSM icon
510
TSMC
TSM
$2.09T
$4.22M 0.03%
18,630
+1,060
+6% +$196K
E icon
511
ENI
E
$76B
$4.21M 0.03%
130,000
– –
JHG
512
DELISTED
Janus Henderson
JHG
$4.17M 0.03%
107,400
+1,700
+2% +$59.9K
SLM icon
513
SLM Corp
SLM
$4.57B
$4.16M 0.03%
127,000
– –
OLN icon
514
Olin
OLN
$2.64B
$4.15M 0.03%
206,552
+105,552
+105% +$2.19M
GBX icon
515
The Greenbrier Companies
GBX
$1.61B
$4.13M 0.03%
89,696
+7,196
+9% +$322K
HTH icon
516
Hilltop Holdings
HTH
$2.29B
$4.08M 0.03%
+134,405
New +$3.99M
LLYVA icon
517
Liberty Live Group Series A
LLYVA
$8.8B
$4.07M 0.03%
51,232
-64
-0.1% -$4.65K
GTLS
518
DELISTED
Chart Industries
GTLS
$4.07M 0.03%
24,689
+14,989
+155% +$2.2M
FBNC icon
519
First Bancorp
FBNC
$2.6B
$4.06M 0.03%
+91,983
New +$3.73M
AP icon
520
Ampco-Pittsburgh
AP
$167M
$4.05M 0.03%
1,367,800
-40,000
-3% -$104K
FBRT
521
Franklin BSP Realty Trust
FBRT
$601M
$4.01M 0.03%
375,000
+94,649
+34% +$1.06M
XIFR
522
XPLR Infrastructure LP
XIFR
$1.18B
$4.01M 0.03%
488,858
-203,592
-29% -$1.77M
GMS
523
DELISTED
GMS Inc
GMS
$4M 0.03%
+36,800
New +$2.85M
APD icon
524
Air Products & Chemicals
APD
$66.3B
$3.95M 0.03%
13,995
-77
-0.5% -$21.1K
VG
525
Venture Global Inc
VG
$35.6B
$3.91M 0.03%
251,200
-8,300
-3% -$96K
19 20
21
22 23

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.